{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T15:06:16Z","timestamp":1789571176557,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T00:00:00Z","timestamp":1713139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T00:00:00Z","timestamp":1713139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Open access funding provided by The Science, Technology & Innovation Funding Authority (STDF) in cooperation\nwith The Egyptian Knowledge Bank"},{"name":"Kafr El Shiekh University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s40263-024-01080-5","type":"journal-article","created":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T15:02:20Z","timestamp":1713193340000},"page":"387-398","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Ticagrelor Versus Clopidogrel in Acute Large-Vessel Ischemic Stroke: A Randomized Controlled Single-Blinded Trial"],"prefix":"10.1007","volume":"38","clinical-trial-number":[{"clinical-trial-number":"nct06120725","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0337-349X","authenticated-orcid":false,"given":"Mohamed G.","family":"Zeinhom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Elbassiouny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Mahmoud","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherihan Rezk","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,15]]},"reference":[{"issue":"Nov","key":"1080_CR1","first-page":"1","volume":"8","author":"K Malhotra","year":"2017","unstructured":"Malhotra K, Gornbein J, Saver JL. Ischemic strokes due to large-vessel occlusions contribute disproportionately to stroke-related dependence and death: a review. Front Neurol. 2017;8(Nov):1\u20135.","journal-title":"Front Neurol"},{"issue":"12","key":"1080_CR2","doi-asserted-by":"publisher","first-page":"3834","DOI":"10.1161\/STROKEAHA.109.561787","volume":"40","author":"WS Smith","year":"2009","unstructured":"Smith WS, Lev MH, English JD, Camargo EC, Chou M, Johnston SC, et al. Significance of large vessel intracranial occlusion causing acute ischemic stroke and tia. Stroke. 2009;40(12):3834\u201340.","journal-title":"Stroke"},{"issue":"1","key":"1080_CR3","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1093\/neuros\/nyz042","volume":"85","author":"RC Rennert","year":"2019","unstructured":"Rennert RC, Wali AR, Steinberg JA, Santiago-Dieppa DR, Olson SE, Pannell JS, et al. Epidemiology, natural history, and clinical presentation of large vessel ischemic stroke. Clin Neurosurg. 2019;85(1):S4-8.","journal-title":"Clin Neurosurg"},{"issue":"1","key":"1080_CR4","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jstrokecerebrovasdis.2007.09.006","volume":"17","author":"DM Meyer","year":"2008","unstructured":"Meyer DM, Albright KC, Allison TA, Grotta JC. LOAD: a pilot study of the safety of loading of aspirin and clopidogrel in acute ischemic stroke and transient ischemic attack. J Stroke Cerebrovasc Dis. 2008;17(1):26\u20139.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"6","key":"1080_CR5","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1161\/CIRCGENETICS.110.958561","volume":"3","author":"US Tantry","year":"2010","unstructured":"Tantry US, Bliden KP, Wei C, Storey RF, Armstrong M, Butler K, et al. First analysis of the relation between CYP2C19 genotype and pharmacodynamics in patients treated with ticagrelor versus clopidogrel: the ONSET\/OFFSET and RESPOND genotype studies. Circ Cardiovasc Genet. 2010;3(6):556\u201366.","journal-title":"Circ Cardiovasc Genet"},{"issue":"2","key":"1080_CR6","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s10072-022-06525-7","volume":"44","author":"HM Aref","year":"2023","unstructured":"Aref HM, El-Khawas H, Elbassiouny A, Shokri HM, Zeinhom MG, Roushdy TM. A randomized pilot study of the efficacy and safety of loading ticagrelor in acute ischemic stroke. Neurol Sci. 2023;44(2):765\u201371. https:\/\/doi.org\/10.1007\/s10072-022-06525-7.","journal-title":"Neurol Sci"},{"issue":"13","key":"1080_CR7","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1212\/WNL.0000000000001972","volume":"85","author":"L Liu","year":"2015","unstructured":"Liu L, Wong KSL, Leng X, Pu Y, Wang Y, Jing J, et al. Dual antiplatelet therapy in stroke and ICAS: subgroup analysis of CHANCE. Neurology. 2015;85(13):1154\u201362.","journal-title":"Neurology"},{"issue":"16","key":"1080_CR8","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1056\/NEJMoa060989","volume":"354","author":"DL Bhatt","year":"2006","unstructured":"Bhatt DL, Fox KAA, Hacke W, Berger PB, Black HR, Boden WE, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med. 2006;354(16):1706\u201317.","journal-title":"N Engl J Med"},{"issue":"9431","key":"1080_CR9","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0140-6736(04)16721-4","volume":"364","author":"HC Diener","year":"2004","unstructured":"Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet (Lond, Engl). 2004;364(9431):331\u20137.","journal-title":"Lancet (Lond, Engl)."},{"issue":"27","key":"1080_CR10","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1056\/NEJMoa2111749","volume":"385","author":"Y Wang","year":"2021","unstructured":"Wang Y, Meng X, Wang A, Xie X, Pan Y, Johnston SC, et al. Ticagrelor versus clopidogrel in CYP2C19 loss-of-function carriers with stroke or TIA. N Engl J Med. 2021;385(27):2520\u201330.","journal-title":"N Engl J Med"},{"key":"1080_CR11","first-page":"1","volume":"365","author":"Y Wang","year":"2019","unstructured":"Wang Y, Chen W, Lin Y, Meng X, Chen G, Wang Z, et al. Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled phase II trial. BMJ. 2019;365:1\u201311.","journal-title":"BMJ"},{"issue":"1","key":"1080_CR12","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1212\/WNL.53.1.126","volume":"53","author":"HPJ Adams","year":"1999","unstructured":"Adams HPJ, Davis PH, Leira EC, Chang KC, Bendixen BH, Clarke WR, et al. Baseline NIH Stroke Scale score strongly predicts outcome after stroke: a report of the Trial of Org 10172 in acute stroke treatment (TOAST). Neurology. 1999;53(1):126\u201331.","journal-title":"Neurology"},{"key":"1080_CR13","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1161\/STR.0000000000000211","volume":"50","author":"WJ Powers","year":"2019","unstructured":"Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke a guideline for healthcare professionals from the American Heart Association\/American Stroke A. Stroke. 2019;50:344\u2013418.","journal-title":"Stroke"},{"issue":"25","key":"1080_CR14","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1161\/CIRCULATIONAHA.117.030509","volume":"136","author":"G Ntaios","year":"2017","unstructured":"Ntaios G, Hart RG. Embolic stroke. Circulation. 2017;136(25):2403\u20135.","journal-title":"Circulation"},{"issue":"5","key":"1080_CR15","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, Bax JJ, Boriani G, Dan GA, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2021;42(5):373\u2013498.","journal-title":"Eur Heart J"},{"issue":"11","key":"1080_CR16","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/j.jacc.2010.11.024","volume":"57","author":"ER Bates","year":"2011","unstructured":"Bates ER, Lau WC, Angiolillo DJ. Clopidogrel-drug interactions. J Am Coll Cardiol. 2011;57(11):1251\u201363.","journal-title":"J Am Coll Cardiol"},{"key":"1080_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s13760-022-02015-x","author":"SR Ahmed","year":"2022","unstructured":"Ahmed SR, Mohamed AAM, Salem HH, Helmy S, Moustafa RR, Borham SMF. Association of white matter hyperintensities with migraine phenotypes and response to treatment. Acta Neurol Belg. 2022. https:\/\/doi.org\/10.1007\/s13760-022-02015-x.","journal-title":"Acta Neurol Belg"},{"issue":"5","key":"1080_CR18","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1161\/01.STR.0000068406.30514.31","volume":"34","author":"J Alvarez-Sab\u00edn","year":"2003","unstructured":"Alvarez-Sab\u00edn J, Molina CA, Montaner J, Arenillas JF, Huertas R, Ribo M, et al. Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator\u2013treated patients. Stroke. 2003;34(5):1235\u201341.","journal-title":"Stroke"},{"issue":"4","key":"1080_CR19","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1001\/jama.2019.9346","volume":"322","author":"KC Johnston","year":"2019","unstructured":"Johnston KC, Bruno A, Pauls Q, Hall CE, Barrett KM, Barsan W, et al. Intensive vs standard treatment of hyperglycemia and functional outcome in patients with acute ischemic stroke: the SHINE Randomized Clinical Trial. JAMA. 2019;322(4):326\u201335. https:\/\/doi.org\/10.1001\/jama.2019.9346.","journal-title":"JAMA"},{"issue":"1","key":"1080_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12944-019-1171-8","volume":"19","author":"YS Yao","year":"2020","unstructured":"Yao YS, Di Li T, Zeng ZH. Mechanisms underlying direct actions of hyperlipidemia on myocardium: an updated review. Lipids Health Dis. 2020;19(1):23. https:\/\/doi.org\/10.1186\/s12944-019-1171-8.","journal-title":"Lipids Health Dis"},{"issue":"10","key":"1080_CR21","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1503\/cmaj.1041561","volume":"172","author":"MD Hill","year":"2005","unstructured":"Hill MD, Buchan AM. Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study. Can Med Assoc J. 2005;172(10):1307\u201312.","journal-title":"Can Med Assoc J"},{"key":"1080_CR22","first-page":"364","volume":"2021","author":"DO Kleindorfer","year":"2021","unstructured":"Kleindorfer DO, Towfighi A, Chaturvedi S, Cockroft KM, Gutierrez J, Lombardi-Hill D, et al. Guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association\/American Stroke Association. Vol. 52. Stroke. 2021;2021:364\u2013467.","journal-title":"Stroke"},{"issue":"1","key":"1080_CR23","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1538-7836.2009.03678.x","volume":"8","author":"S Schulman","year":"2010","unstructured":"Schulman S, Anger SU, Bergqvist D, Eriksson B, Lassen MR, Fisher W. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients. J Thromb Haemost. 2010;8(1):202\u20134.","journal-title":"J Thromb Haemost"},{"key":"1080_CR24","unstructured":"Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, et al. N Engl J. 2011;1317\u201329."},{"issue":"9558","key":"1080_CR25","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0140-6736(07)60149-4","volume":"369","author":"N Wahlgren","year":"2007","unstructured":"Wahlgren N, Ahmed N, D\u00e1valos A, Ford GA, Grond M, Hacke W, et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet. 2007;369(9558):275\u201382.","journal-title":"Lancet"},{"issue":"6","key":"1080_CR26","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1161\/01.STR.0000018645.04200.7D","volume":"33","author":"AJ Furlan","year":"2002","unstructured":"Furlan AJ. Acute stroke trials: Strengthening the underpowered. Stroke. 2002;33(6):1450\u20131.","journal-title":"Stroke"},{"issue":"11","key":"1080_CR27","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa1105335","volume":"365","author":"MI Chimowitz","year":"2011","unstructured":"Chimowitz MI, Lynn MJ, Derdeyn CP, Turan TN, Fiorella D, Lane BF, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med. 2011;365(11):993\u20131003.","journal-title":"N Engl J Med"},{"issue":"1","key":"1080_CR28","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1056\/NEJMoa1603060","volume":"375","author":"SC Johnston","year":"2016","unstructured":"Johnston SC, Amarenco P, Albers GW, Denison H, Easton JD, Evans SR, et al. Ticagrelor versus aspirin in acute stroke or transient ischemic attack. N Engl J Med. 2016;375(1):35\u201343.","journal-title":"N Engl J Med"},{"issue":"4","key":"1080_CR29","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S1474-4422(17)30038-8","volume":"16","author":"P Amarenco","year":"2017","unstructured":"Amarenco P, Albers GW, Denison H, Easton JD, Evans SR, Held P, et al. Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial. Lancet Neurol. 2017;16(4):301\u201310. https:\/\/doi.org\/10.1016\/S1474-4422(17)30038-8.","journal-title":"Lancet Neurol"},{"issue":"3","key":"1080_CR30","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1056\/NEJMoa1916870","volume":"383","author":"SC Johnston","year":"2020","unstructured":"Johnston SC, Amarenco P, Denison H, Evans SR, Himmelmann A, James S, et al. Ticagrelor and aspirin or aspirin alone in acute ischemic stroke or TIA. N Engl J Med. 2020;383(3):207\u201317.","journal-title":"N Engl J Med"},{"issue":"21","key":"1080_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1161\/JAHA.123.031611","volume":"12","author":"C Wang","year":"2023","unstructured":"Wang C, Jia W, Jing J, Meng X, Wang A, Xu Q, et al. Ticagrelor versus clopidogrel in minor stroke or transient ischemic attack with intracranial artery stenosis: a post hoc analysis of CHANCE-2. J Am Heart Assoc. 2023;12(21):1\u201312.","journal-title":"J Am Heart Assoc"},{"issue":"11","key":"1080_CR32","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa1105335","volume":"365","author":"MI Chimowitz","year":"2013","unstructured":"Chimowitz MI, Lynn MJ, Derdeyn CP, Turan TN, Fiorella D, Lane BF, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis for the SAMMPRIS Trial Investigators *. N Engl J Med. 2013;365(11):993\u20131003.","journal-title":"N Engl J Med"},{"issue":"9","key":"1080_CR33","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1001\/jamaneurol.2021.2440","volume":"78","author":"Y Wang","year":"2021","unstructured":"Wang Y, Pan Y, Li H, Amarenco P, Denison H, Evans SR, et al. Efficacy and safety of ticagrelor and aspirin in patients with moderate ischemic stroke: an exploratory analysis of the THALES randomized clinical trial. JAMA Neurol. 2021;78(9):1091\u20138. https:\/\/doi.org\/10.1001\/jamaneurol.2021.2440.","journal-title":"JAMA Neurol"},{"issue":"20","key":"1080_CR34","doi-asserted-by":"publisher","first-page":"20085","DOI":"10.18632\/aging.103452","volume":"12","author":"Y Yang","year":"2020","unstructured":"Yang Y, Chen W, Pan Y, Yan H, Meng X, Liu L, et al. Effect of ticagrelor versus clopidogrel on platelet reactivity measured by thrombelastography in patients with minor stroke or TIA. Aging (Albany NY). 2020;12(20):20085\u201394.","journal-title":"Aging (Albany NY)."},{"issue":"7","key":"1080_CR35","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/FPC.0b013e3283385420","volume":"20","author":"K Sangkuhl","year":"2010","unstructured":"Sangkuhl K, Klein TE, Altman RB. Clopidogrel pathway. Pharmacogenet Genom. 2010;20(7):463\u20135.","journal-title":"Pharmacogenet Genom"},{"issue":"2","key":"1080_CR36","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1161\/01.STR.25.2.278","volume":"25","author":"KF Van","year":"1994","unstructured":"Van KF, Ciabattoni G, Patrono C, Schmitz PIM, Van GJ, Koudstaal PJ. Evidence for episodic platelet activation in acute ischemic stroke. Stroke. 1994;25(2):278\u201381.","journal-title":"Stroke"},{"issue":"16","key":"1080_CR37","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1016\/j.jcin.2017.05.064","volume":"10","author":"HS Jeong","year":"2017","unstructured":"Jeong HS, Hong SJ, Cho SA, Kim JH, Cho JY, Lee SH, et al. Comparison of ticagrelor versus prasugrel for inflammation vascular function, and circulating endothelial progenitor cells in diabetic patients with non-ST-segment elevation acute coronary syndrome requiring coronary stenting: a prospective, randomized. JACC Cardiovasc Interv. 2017;10(16):1646\u201358.","journal-title":"JACC Cardiovasc Interv"},{"issue":"6","key":"1080_CR38","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s10557-016-6701-2","volume":"30","author":"Y Birnbaum","year":"2016","unstructured":"Birnbaum Y, Birnbaum GD, Birnbaum I, Nylander S, Ye Y. Ticagrelor and rosuvastatin have additive cardioprotective effects via adenosine. Cardiovasc drugs Ther. 2016;30(6):539\u201350.","journal-title":"Cardiovasc drugs Ther"},{"issue":"3","key":"1080_CR39","first-page":"4195","volume":"17","author":"M Dehbozorgi","year":"2018","unstructured":"Dehbozorgi M, Kamalidehghan B, Hosseini I, Dehghanfard Z, Sangtarash MH, Firoozi M, et al. Prevalence of the CYP2C19*2 (681 G>A), *3 (636 G>A) and *17 (-806 C>T) alleles among an Iranian population of different ethnicities. Mol Med Rep. 2018;17(3):4195\u2013202.","journal-title":"Mol Med Rep"},{"issue":"7","key":"1080_CR40","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.1111\/bcp.15282","volume":"88","author":"C Minderhoud","year":"2022","unstructured":"Minderhoud C, Otten LS, Hilkens PHE, van den Broek MPH, Harmsze AM. Increased frequency of CYP2C19 loss-of-function alleles in clopidogrel-treated patients with recurrent cerebral ischemia. Br J Clin Pharmacol. 2022;88(7):3335\u201340. https:\/\/doi.org\/10.1111\/bcp.15282.","journal-title":"Br J Clin Pharmacol"},{"issue":"10088","key":"1080_CR41","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1016\/S0140-6736(17)31075-9","volume":"389","author":"A Gupta","year":"2017","unstructured":"Gupta A, Thompson D, Whitehouse A, Collier T, Dahlof B, Poulter N, et al. Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial\u2014Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension p. Lancet. 2017;389(10088):2473\u201381.","journal-title":"Lancet"}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-024-01080-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40263-024-01080-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-024-01080-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T16:18:48Z","timestamp":1713457128000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40263-024-01080-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,15]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["1080"],"URL":"https:\/\/doi.org\/10.1007\/s40263-024-01080-5","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,15]]},"assertion":[{"value":"6 March 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Open access funding provided by The Science, Technology & Innovation Funding Authority (STDF) in cooperation\nwith The Egyptian Knowledge Bank (EKB). This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Mohamed G. Zeinhom, Ahmed Elbassiouny, Ahmed Mahmoud Mohamed, and Sherihan Rezk Ahmed declare that they have no potential conflicts of interest that might be relevant to the contents of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Dr Zeinhom and Dr Ahmed were the principal investigators, Dr Zeinhom and Dr Elbassiouny were the main supervisors of the study; Dr Mohamed shared in the study plan revision and supervision, while Dr Zeinhom shared in manuscript writing. All authors reviewed and edited the manuscript and approved the final version of the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}},{"value":"Our study had the approval of the ethical committee of Kafr El-Sheikh University, and the ethical reference number is (MKSU:50-9-6).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Written informed consent was obtained from all subjects before the study.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The datasets generated during and\/or analyzed during the current study are available from Mohamed G. Zeinhom on reasonable request.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Availability"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}}]}}